Log in | Register

Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient dataOpen access

Matthieu Jabaudon| Raiko Blondonnet| Bruno Pereira| Rodrigo Cartin-Ceba| Christoph Lichtenstern| Tommaso Mauri| Rogier M. Determann| Tomas Drabek| Rolf D. Hubmayr| Ognjen Gajic| Florian Uhle| Andrea Coppadoro| Antonio Pesenti| Marcus J. Schultz| Marco V. Ranieri| Helena Brodska| Ségolène Mrozek| Vincent Sapin| Michael A. Matthay| Jean-Michel Constantin| Carolyn S. Calfee
Original
Volume 44, Issue 9 / September , 2018

Pages 1388 - 1399

Abstract

Purpose

The soluble receptor for advanced glycation end-products (sRAGE) is a marker of lung epithelial injury and alveolar fluid clearance (AFC), with promising values for assessing prognosis and lung injury severity in acute respiratory distress syndrome (ARDS). Because AFC is impaired in most patients with ARDS and is associated with higher mortality, we hypothesized that baseline plasma sRAGE would predict mortality, independently of two key mediators of ventilator-induced lung injury.

Methods

We conducted a meta-analysis of individual data from 746 patients enrolled in eight prospective randomized and observational studies in which plasma sRAGE was measured in ARDS articles published through March 2016. The primary outcome was 90-day mortality. Using multivariate and mediation analyses, we tested the association between baseline plasma sRAGE and mortality, independently of driving pressure and tidal volume.

Results

Higher baseline plasma sRAGE [odds ratio (OR) for each one-log increment, 1.18; 95% confidence interval (CI) 1.01–1.38; P = 0.04], driving pressure (OR for each one-point increment, 1.04; 95% CI 1.02–1.07; P = 0.002), and tidal volume (OR for each one-log increment, 1.98; 95% CI 1.07–3.64; P = 0.03) were independently associated with higher 90-day mortality in multivariate analysis. Baseline plasma sRAGE mediated a small fraction of the effect of higher ΔP on mortality but not that of higher VT.

Conclusions

Higher baseline plasma sRAGE was associated with higher 90-day mortality in patients with ARDS, independently of driving pressure and tidal volume, thus reinforcing the likely contribution of alveolar epithelial injury as an important prognostic factor in ARDS. Registration: PROSPERO (ID: CRD42018100241).

Keywords

References

  1. Definition Task Force ARDS, Ranieri VM, Rubenfeld GD et al (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307:2526–2533
  2. Bellani G, Laffey JG, Pham T et al (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315:788–800
    • View reference on publisher's website
    • View reference on PubMed
  3. Matthay MA, Zimmerman GA, Esmon C et al (2003) Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 167:1027–1035
    • View reference on publisher's website
    • View reference on PubMed
  4. Matthay MA, Wiener-Kronish JP (1990) Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 142:1250–1257
    • View reference on publisher's website
    • View reference on PubMed
  5. Matthay MA (2014) Resolution of pulmonary edema. Thirty years of progress. Am J Respir Crit Care Med 189:1301–1308
    • View reference on publisher's website
    • View reference on PubMed
  6. Uchida T, Shirasawa M, Ware LB et al (2006) Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 173:1008–1015
    • View reference on publisher's website
    • View reference on PubMed
  7. Calfee CS, Ware LB, Eisner MD et al (2008) Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 63:1083–1089
    • View reference on publisher's website
    • View reference on PubMed
  8. Jabaudon M, Blondonnet R, Roszyk L et al (2015) Soluble receptor for advanced glycation end-products predicts impaired alveolar fluid clearance in acute respiratory distress syndrome. Am J Respir Crit Care Med 192:191–199
    • View reference on publisher's website
    • View reference on PubMed
  9. Bierhaus A, Humpert PM, Morcos M et al (2005) Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 83:876–886
    • View reference on publisher's website
    • View reference on PubMed
  10. Ray P, Le Manach Y, Riou B, Houle TT (2010) Statistical evaluation of a biomarker. Anesthesiology 112:1023–1040
    • View reference on publisher's website
    • View reference on PubMed
  11. Jabaudon M, Futier E, Roszyk L et al (2011) Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit Care Med 39:480–488
    • View reference on publisher's website
    • View reference on PubMed
  12. Jabaudon M, Blondonnet R, Roszyk L et al (2015) Soluble forms and ligands of the receptor for advanced glycation end-products in patients with acute respiratory distress syndrome: an observational prospective study. PLoS One 10:e0135857
    • View reference on publisher's website
    • View reference on PubMed
  13. Calfee CS, Budev MM, Matthay MA et al (2007) Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation. J Heart Lung Transpl 26:675–680
    • View reference on publisher's website
  14. Mrozek S, Jabaudon M, Jaber S et al (2016) Elevated plasma levels of sRAGE are associated with nonfocal CT-based lung imaging in patients with ARDS: a prospective multicenter study. Chest 150:998–1007
    • View reference on publisher's website
    • View reference on PubMed
  15. Jabaudon M, Hamroun N, Roszyk L et al (2015) Effects of a recruitment maneuver on plasma levels of soluble RAGE in patients with diffuse acute respiratory distress syndrome: a prospective randomized crossover study. Intensive Care Med 41:846–855
  16. Jabaudon M, Blondonnet R, Lutz J et al (2016) Net alveolar fluid clearance is associated with lung morphology phenotypes in acute respiratory distress syndrome. Anaesth Crit Care Pain Med 35:81–86
    • View reference on publisher's website
    • View reference on PubMed
  17. Gattinoni L, Pesenti A (2005) The concept of “baby lung”. Intensive Care Med 31:776–784
  18. Amato MBP, Meade MO, Slutsky AS et al (2015) Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 372:747–755
    • View reference on publisher's website
    • View reference on PubMed
  19. Samary CS, Santos RS, Santos CL et al (2015) Biological impact of transpulmonary driving pressure in experimental acute respiratory distress syndrome. Anesthesiology 123:423–433
    • View reference on publisher's website
    • View reference on PubMed
  20. Imai K, Keele L, Tingley D, Yamamoto T (2011) Unpacking the black box of causality: learning about causal mechanisms from experimental and observational studies. Am Polit Sci Rev 105:765–789
    • View reference on publisher's website
  21. Stewart LA, Clarke M, Rovers M et al (2015) Preferred reporting items for a systematic review and meta-analysis of individual participant data: the PRISMA-IPD Statement. JAMA 313:1657–1665
    • View reference on publisher's website
    • View reference on PubMed
  22. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829
    • View reference on publisher's website
    • View reference on PubMed
  23. Knaus WA, Wagner DP, Draper EA et al (1991) The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100:1619–1636
    • View reference on publisher's website
    • View reference on PubMed
  24. Vincent JL, Moreno R, Takala J et al (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. on behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710
  25. O’Brien PC (1984) Procedures for comparing samples with multiple endpoints. Biometrics 40:1079–1087
    • View reference on publisher's website
    • View reference on PubMed
  26. Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387
    • View reference on publisher's website
    • View reference on PubMed
  27. Malek MH, Berger DE, Coburn JW (2007) On the inappropriateness of stepwise regression analysis for model building and testing. Eur J Appl Physiol 101:263–264 (author reply 265–6)
    • View reference on publisher's website
    • View reference on PubMed
  28. Shrout PE, Bolger N (2002) Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods 7:422–445
    • View reference on publisher's website
    • View reference on PubMed
  29. Cartin-Ceba R, Hubmayr RD, Qin R et al (2015) Predictive value of plasma biomarkers for mortality and organ failure development in patients with acute respiratory distress syndrome. J Crit Care 30(219):e1–e7
  30. Brodska H, Malickova K, Valenta J et al (2013) Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsis. Scand J Clin Lab Invest 73:650–660
    • View reference on publisher's website
    • View reference on PubMed
  31. Mauri T, Masson S, Pradella A et al (2010) Elevated plasma and alveolar levels of soluble receptor for advanced glycation end products are associated with severity of lung dysfunction in ARDS patients. Tohoku J Exp Med 222:105–112
    • View reference on publisher's website
    • View reference on PubMed
  32. Determann RM, Royakkers AANM, Haitsma JJ et al (2010) Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients. BMC Pulm Med 10:6
    • View reference on publisher's website
    • View reference on PubMed
  33. Krull JL, MacKinnon DP (2001) Multilevel modeling of individual and group level mediated effects. Multivar Behav Res 36:249–277
    • View reference on publisher's website
  34. Guérin C, Papazian L, Reignier J et al (2016) Effect of driving pressure on mortality in ARDS patients during lung protective mechanical ventilation in two randomized controlled trials. Crit Care 20:384
    • View reference on publisher's website
    • View reference on PubMed
  35. Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART) Investigators, Cavalcanti AB, Suzumura ÉA et al (2017) Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs Low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 318:1335–1345
    • View reference on publisher's website
  36. Neto AS, Hemmes SNT, Barbas CSV et al (2016) Association between driving pressure and development of postoperative pulmonary complications in patients undergoing mechanical ventilation for general anaesthesia: a meta-analysis of individual patient data. Lancet Respir Med 4:272–280
    • View reference on publisher's website
    • View reference on PubMed
  37. Calfee CS, Delucchi K, Parsons PE et al (2014) Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2:611–620
    • View reference on publisher's website
    • View reference on PubMed
  38. Famous KR, Delucchi K, Ware LB et al (2017) Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med 195:331–338
    • View reference on PubMed
  39. Shirasawa M, Fujiwara N, Hirabayashi S et al (2004) Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes Cells 9:165–174
    • View reference on publisher's website
    • View reference on PubMed
  40. Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342:1334–1349
    • View reference on publisher's website
    • View reference on PubMed
  41. Ware LB, Matthay MA (2001) Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 163:1376–1383
    • View reference on publisher's website
    • View reference on PubMed
  42. Briot R, Frank JA, Uchida T et al (2009) Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs. Chest 135:269–275
    • View reference on publisher's website
    • View reference on PubMed
  43. Calfee CS, Janz DR, Bernard GR et al (2015) Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest 147:1539–1548
    • View reference on publisher's website
    • View reference on PubMed
  44. Parsons PE, Eisner MD, Thompson BT et al (2005) Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 33:1–6 (discussion 230–2)
    • View reference on publisher's website
    • View reference on PubMed
  45. Guo WA, Knight PR, Raghavendran K (2012) The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome. Intensive Care Med 38:1588–1598
  46. Mukherjee TK, Mukhopadhyay S, Hoidal JR (2008) Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology. Respir Physiol Neurobiol 162:210–215
    • View reference on publisher's website
    • View reference on PubMed
  47. Dreyfuss D, Soler P, Basset G, Saumon G (1988) High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 137:1159–1164
    • View reference on publisher's website
    • View reference on PubMed
  48. Tschumperlin DJ, Oswari J, Margulies AS (2000) Deformation-induced injury of alveolar epithelial cells. Effect of frequency, duration, and amplitude. Am J Respir Crit Care Med 162:357–362
    • View reference on publisher's website
    • View reference on PubMed
  49. Nuckton TJ, Alonso JA, Kallet RH et al (2002) Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med 346:1281–1286
    • View reference on publisher's website
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement